How Immuno-Oncology Biomarkers Are Changing Cancer Care
|
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients. |
Read More
|
|
Understanding Both Sides of the Copay Accumulator Debate
|
At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.
|
Read More
|